Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Machine learning based on prediagnostic metabolomic profiles identifies distinct subtypes of exfoliation glaucoma
Author Affiliations & Notes
  • Akiko Hanyuda
    Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
  • Oana A. Zeleznik
    Brigham and Women's Hospital Channing Division of Network Medicine, Boston, Massachusetts, United States
  • Yoshihiko Raita
    Okinawa Kenritsu Chubu Byoin, Uruma, Okinawa, Japan
  • Kazuno Negishi
    Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
  • Louis R Pasquale
    Icahn School of Medicine at Mount Sinai Department of Ophthalmology, New York, New York, United States
  • Janey L Wiggs
    Harvard Medical School, Boston, Massachusetts, United States
  • Jae H Kang
    Brigham and Women's Hospital Channing Division of Network Medicine, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Akiko Hanyuda Keio University School of Medicine, Code P (Patent); Oana A. Zeleznik None; Yoshihiko Raita None; Kazuno Negishi Suntory Holdings Limited, Code F (Financial Support), Shin Nippon Biomedical Laboratories, LTD. (SNBL), Code F (Financial Support), SUNSTAR, Code F (Financial Support), Dainippon Pharmaceutical, Code F (Financial Support), Yakult Honsha Co.,Ltd., Code F (Financial Support), Keio University School of Medicine, Code P (Patent); Louis Pasquale Twenty Twenty, Code C (Consultant/Contractor), Character Biosciences, Code C (Consultant/Contractor); Janey Wiggs Allergan, Code C (Consultant/Contractor), Avellino, Code C (Consultant/Contractor), Editas, Code C (Consultant/Contractor), Maze, Code C (Consultant/Contractor), Regenxbio, Code C (Consultant/Contractor), Aerpio, Code F (Financial Support); Jae Kang Pfizer, Inc., Code F (Financial Support)
  • Footnotes
    Support  NIH/NEI R01 EY020928, R01 EY015473
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 998. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Akiko Hanyuda, Oana A. Zeleznik, Yoshihiko Raita, Kazuno Negishi, Louis R Pasquale, Janey L Wiggs, Jae H Kang; Machine learning based on prediagnostic metabolomic profiles identifies distinct subtypes of exfoliation glaucoma. Invest. Ophthalmol. Vis. Sci. 2024;65(7):998.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Exfoliation glaucoma (XFG) exhibits genetic and environmental heterogeneity in etiology; however, distinct etiologic endotypes of XFG have not been delineated. We aimed to use unsupervised machine learning on prediagnostic plasma metabolites to characterize distinct etiologic XFG endotypes.

Methods : We collected blood samples from participants of the Nurses’ Health Study in 1989-1990, and the Health Professionals Follow-up Study in 1993-1995. Liquid chromatography-mass spectrometry was used to profile 379 plasma metabolites. During a mean follow-up period of 11.8 years until 2016, we identified 205 incident XFG cases, confirmed with medical record information. In this case-only analysis, after preprocessing of pre-diagnostic metabolites with adjustment for season, time of blood draw, and fasting status, we computed a distance matrix using Pearson distance. We then computed gap statistics to determine the optimal number of endotypes. XFG risk factors, clinical presentations, and metabolomic profiles were compared across endotypes. False discovery rate (FDR) was used to account for multiple comparisons in Metabolite Set Enrichment Analyses.

Results : We identified three distinct endotypes. Compared with the reference group (endotype 2, the most common endotype (n=90; 43.9%), endotype 1 (n=56; 27.3%) tended to be male southern US residents with greater UV exposure and were least likely to have cardiovascular disease; among women, there was a higher percentage of postmenopausal status. Endotype 3 (n=59; 28.8%) was associated with being a male northern US resident and having a higher body mass index, a higher prevalence of cardiovascular disease, diabetes, hypertension, and dyslipidemia, and the lowest genetic susceptibility (e.g., lowest occurrence of the XFG risk allele rs7329408 in POMP). There were no differences in ophthalmic characteristics (e.g., maximum intraocular pressure, bilaterality, age at diagnosis) across endotypes (P≥0.6). In metabolite class enrichment analyses, compared with endotype 2, organic acids and carnitines were positively associated with endotype 1 while diglycerides and triglycerides were positively associated with endotype 3 (FDR<0.05).

Conclusions : Integrated metabolomic profiling identified distinct XFG etiologic endotypes, suggesting different pathobiological mechanisms and susceptibilities to genetic and environmental XFG risk factors.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×